Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Scangos Leaves Biogen Transformed And Transitioning

Jul 21 2016

• By Jessica Merrill

Scangos_George_1200x675 — • Source: Biogen Inc.

Related Content

Biogen Sets A High R&D Bar With A Pipeline That Extends Well Beyond MS

Nov 16 2015

Biogen Anti-LINGO MS Study Failure Removes Upside

Jun 08 2016

Belt-Tightening Biogen Looks To Narrow Therapeutic Focus

Oct 22 2015

Biogen Makes Counterintuitive Move To Tap Exelixis's Scangos As CEO

Jul 05 2010

Related Companies

Biogen, Inc.

Merck & Co., Inc.

Pfizer Inc.

Johnson & Johnson

Exelixis, Inc.

Additional Topics

Commercial Companies Business Strategies Leadership Strategy BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.